Biotie Therapies Corp Aktie

Aktien

Verzögert Nasdaq Helsinki Andere Börsenplätze			% 5 Tage	% 1. Jan.
- ^EUR	-.--%		-.--%	-.--%

Dauer

Zeitraum

Stil

Biotie Therapies : ACORDA GAINS TITLE TO BIOTIE SHARES AND THE SHARES WILL DELIST	30.09.16
Biotie Therapies : ARBITRAL TRIBUNAL CONFIRMED ACORDA'S REDEMPTION RIGHT REGARDING BIOTIE SHARES AND BIOTIE SHARES TRADING HAS BEEN TERMINATED	26.09.16
Biotie: BTT1023 receives Orphan Drug Designation in the United States	26.08.16
Biotie Therapies : THE LISTING COMMITTEE OF NASDAQ HELSINKI HAS RESOLVED TO DELIST THE SHARES OF BIOTIE THERAPIES CORP.	25.08.16
Biotie Therapies : CORP. APPLIES FOR DELISTING OF ITS SHARES FROM NASDAQ HELSINKI	18.08.16

Manager	Titel	Alter	Seit
Antero Kallio CEO	Chief Executive Officer	64	01.06.05

Aufsichtsräte	Titel	Alter	Seit
Ronald Cohen CHM	Chairman	68	01.05.16
Jane Wasman BRD	Director/Board Member	67	01.05.16
Andrew Hindman BRD	Director/Board Member	51	01.12.16

Sektor

	% 1. Jan.	Kap.
VERTEX PHARMACEUTICALS INCORPORATED	-0,95 %	104 Mrd.
REGENERON PHARMACEUTICALS, INC.	+6,45 %	97,47 Mrd.
ARGENX SE	+5,71 %	22,25 Mrd.
BIONTECH SE	-12,74 %	21,68 Mrd.
GENMAB A/S	-9,70 %	18,2 Mrd.
WUXI APPTEC CO., LTD.	-39,98 %	17,02 Mrd.
BEIGENE, LTD.	-10,18 %	16,36 Mrd.
NEUROCRINE BIOSCIENCES, INC.	+8,35 %	14,39 Mrd.
SAREPTA THERAPEUTICS, INC.	+38,19 %	12,37 Mrd.